TUBE INVESTMENTS: Q1 CONS NET PROFIT 1.7B RUPEES VS 3B (YOY)

NATCO PHARMA LIMITED: BOARD DECLARES INTERIM DIVIDEND OF ₹1.50 PER SHARE

NATCO PHARMA: CO APPROVED FUND RAISING UP TO 20B RUPEES

PRAKASH PIPES: Q1 EBITDA 182M RUPEES VS 163M (YOY) || Q1 EBITDA MARGIN 7.54% VS 8.01% (YOY)

PRAKASH PIPES: Q1 REVENUE 2.4B RUPEES VS 2B (YOY)

NATCO PHARMA: Q1 REVENUE 7.3B RUPEES VS 13.3B (YOY)

NATCO PHARMA: Q1 EBITDA 1.86B RUPEES VS 5.7B (YOY) || Q1 EBITDA MARGIN 25.4% VS 42.97% (YOY)

NATCO PHARMA: Q1 CONS NET PROFIT 2.1B RUPEES VS 4.8B (YOY)

PRAKASH PIPES: Q1 SL NET PROFIT 164M RUPEES VS 103M (YOY)

ALKEM LAB: Q1 REVENUE 37B RUPEES VS 33.7B (YOY)

ALKEM LAB: Q1 EBITDA 7.7B RUPEES VS 7.4B (YOY) || Q1 EBITDA MARGIN 20.48% VS 21.9% (YOY)

BHARAT DYNAMICS: Q1 EBITDA GAIN 831M RUPEES VS LOSS 454M (YOY) || Q1 EBITDA MARGIN 14.52%

ALKEM LAB: Q1 CONS NET PROFIT 5.2B RUPEES VS 6.6B (YOY)

BHARAT DYNAMICS: Q1 REVENUE 5.7B RUPEES VS 2.5B (YOY)

BHARAT DYNAMICS: Q1 SL NET PROFIT 1.2B RUPEES VS 183M (YOY)

LIKHITHA INFRASTRUCTURE: Q1 EBITDA 110M RUPEES VS 192M (YOY) || Q1 EBITDA MARGIN 12.9% VS 15.72% (YOY)

LIKHITHA INFRASTRUCTURE: Q1 SL NET PROFIT 73M RUPEES VS 139M (YOY) || Q1 REVENUE 851M RUPEES VS 1.22B (YOY)